Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.

Source:http://linkedlifedata.com/resource/pubmed/id/19801938

Download in:

View as

General Info

PMID
19801938